LYNCH JOHN EDWARD exercised options at IGC PHARMA, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 2 exercises
Filed: 6/28/2022ACC: 0001185185-22-000782
+150K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
5
Total transactions
187.50K acquired · 37.50K disposed
Non-Derivative Transactions2
COMMON STOCK
Direct
Shares
+28.13K
Price / share
—
Trade value
—
% of position
29.0%
5/31/2022
96.90K→125.03K
COMMON STOCK
Direct
Shares
+9.38K
Price / share
—
Trade value
—
% of position
7.5%
6/1/2022
125.03K→134.40K
Total
Net shares
+37.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK Direct | 5/31/2022 | M · Option Exercise | +28.13K | — | — | 29.0% | 96.90K | 125.03K |
| COMMON STOCK Direct | 6/1/2022 | M · Option Exercise | +9.38K | — | — | 7.5% | 125.03K | 134.40K |
| Total | +37.50K | $0.00 | ||||||
Derivative Transactions3
Restricted Stock Units
Direct
Converts to
Common Stock
150K shares
Shares
+150K
Strike price
0.0
Held after
300K
Exercisable
—
12/20/2021
Restricted Stock Units
Direct
Converts to
Common Stock
28.13K shares
Shares
−28.13K
Strike price
0.0
Held after
271.88K
Exercisable
—
5/31/2022
Restricted Stock Units
Direct
Converts to
Common Stock
9.38K shares
Shares
−9.38K
Strike price
0.0
Held after
262.50K
Exercisable
—
6/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock150K shares | 12/20/2021 | A · Award | +150K | 0.0 | — | 300K |
| Restricted Stock Units Direct | Common Stock28.13K shares | 5/31/2022 | M · Option Exercise | −28.13K | 0.0 | — | 271.88K |
| Restricted Stock Units Direct | Common Stock9.38K shares | 6/1/2022 | M · Option Exercise | −9.38K | 0.0 | — | 262.50K |